We apply our expertise in Heart, Renal, Hepatic, Metabolic and Co-morbid disease to design and execute comprehensive in vivo pharmacology strategies that generate the high-quality data needed to select the most promising lead candidates. We also develop translational data packages that connect preclinical findings to clinical strategy, informing trial design, biomarker selection, dose rationale, and patient stratification to improve the likelihood of clinical success.
Assessment of Novel Therapeutic Targets and Pathways for Drug Development
Selection of Predictive and Clinically Relevant Disease Models for Human Translatable Results
Define Profile, Design Testing Scheme and Integrated Data Compilation
Elucidation of Mechanistic Pharmacology to Confirm Target Engagement and Biological Response
Full Lifecycle Support covering Design, Monitoring, Study Interpretation and Documentation
Strategic Vendor Selection, Price Negotiation and Oversight to ensure Milestone Delivery
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.